News

GRP Hires Mitchel Allen-Rivera as new Executive Vice President of Business Development

The Greater Richmond Partnership (“GRP”), the lead regional economic development organization serving the City of Richmond and counties of Chesterfield, Hanover and Henrico in Virginia, announces that Mitchel Allen-Rivera is the new Executive Vice President of Business Development.

“I am thrilled to welcome Mitchel to Greater Richmond to lead business development,” said Jennifer Wakefield, President and CEO of the Greater Richmond Partnership. “He is a rockstar economic development professional with a stellar reputation and has repeatedly been recognized among the best in the industry.”

Allen-Rivera is relocating to Greater Richmond, Va., from Phoenix, Ariz., where he has worked as the Senior Vice President of Business Development for the Greater Phoenix Economic Council (GPEC) for nearly a decade in roles of increasing responsibility. In addition to his time at GPEC, he worked at the local level in the City of Chandler, Ariz., and as a manager in the financial services industry.

“I am truly honored to be joining such an exceptional team of professionals under Jennifer Wakefield’s leadership,” said Allen-Rivera. “Richmond is an amazing community full of talent and I am eager to contribute to the region’s future development.”

Allen-Rivera has a bachelor’s degree in communication from Arizona State University and is currently pursuing a master of business administration (MBA) from the University of Denver. He has been recognized twice among the Top 50 economic developers in North America by Consultant Connect, been named as a top 40 under 40 professional in economic development by Development Counsellors International and the International Economic Development Council and as Economic Developer of the Year by the Arizona Association for Economic Development.

Recent News

07/15/2026

Focused Ultrasound Foundation Chairman Receives Lifetime Impact Award

Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural Lifetime Impact Award at the 2026 annual meeting of the International Society for Therapeutic Ultrasound (ISTU) in Norway in June. The award honors individuals whose work has fundamentally shaped the development, adoption, and global impact of focused ultrasound. “Dr. Kassell’s

07/14/2026

ARPA-H awards up to $160 million to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, today announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program — a critical investment toward bringing new treatments to patients faster and cure rare genetic pediatric diseases. THRIVE

07/09/2026

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for QRX003 for the treatment of Peeling Skin Syndrome (PSS), enabling initiation of its planned Phase 2 clinical study. Quoin